Pulmonary function studies were carried out during pregnancy in 8 normal women, in 8 patients with valvular (either mitral or aortic) heart disease, and in 8 patients with chronic pulmonary disease (either emphysema or sarcoidosis). In healthy pregnant women, changes in lung volumes and maximal expiratory flow rates were not significant. Diffusing capacity tended to decrease associated with unchanged pulmonary capillary blood volume. In patients with valvular heart disease, ventilation and oxygen consumption increased toward the term. The patients with mitral valve lesions showed a significant decrease in diffusing capacity with an increase in pulmonary capillary blood volume. In patients wth emphysema, characteristic changes were increasing obstructive functional abnormalities associated with an increase in pulmonary diffusing capacity and pulmonary capillary blood volume. None of these patients, however, had clinical evidence of deterioration of their disease. Patients with sarcoidosis had no appreciable alteration in pulmonary function tests.
Pulmonary function studies were carried out during pregnancy in 8 normal women, in 8 patients with valvular (either mitral or aortic) heart disease, and in 8 patients with chronic pulmonary disease (either emphysema or sarcoidosis). In healthy pregnant women, changes in lung volumes and maximal expiratory flow rates were not significant. Diffusing capacity tended to decrease associated with unchanged pulmonary capillary blood volume. In patients with valvular heart disease, ventilation and oxygen consumption increased toward the term. The patients with mitral valve lesions showed a significant decrease in diffusing capacity with an increase in pulmonary capillary blood volume. In patients wth emphysema, characteristic changes were increasing obstructive functional abnormalities associated with an increase in pulmonary diffusing capacity and pulmonary capillary blood volume. None of these patients, however, had clinical evidence of deterioration of their disease. Patients with sarcoidosis had no appreciable alteration in pulmonary function tests.
The influence of various factors, such as increased ovarian hormones, ventilation-perfusion relationships, intra-abdominal distension, and cardiac haemodynamics, are discussed in relation to the change in pulmonary diffusing capacity and pulmonary capillary blood volume. From the standpoint of pulmonary function studies we think that patients with mitral heart disease and those with pulmonary emphysema tolerate pregnancy less favourably than normal subjects and patients with sarcoidosis.
The influence of pregnancy on pulmonary function has been reported by many workers. While some investigators found that pregnancy has little effect on overall respiratory function, others felt that such factors as the gradual abdominal distension, the enlarged breasts, and the inherent circulatory changes do indeed affect the respiratory physiology in the pregnant woman. In the chronically ill patient, it is even more difficult to overlook the progression of respiratory symptoms and the diminution of cardiac reserve during the second half of pregnancy and during the early post-partum period. Part Meneely and Kaltreider (1949) , minute ventilation (MV), oxygen uptake (V02), ventilatory equivalent for oxygen (VEO), simultaneous measurements of maximum expiratory flow-volume (MEFV), and forced vital capacity (FVC) curves, as described by Gazioglu, Condemi, Kaltreider, and Yu (1968) , and deternination of breath-holding carbon monoxide diffusing capacity (DL), pulmonary membrane diffusing capacity (Dx), and pulmonary capillary blood volume (VN) of Forster, Roughton, Cander, Briscoe, and Kreuser (1957) . A comparison of subdivisions of lung volumes, MEFV, and FVC in each period was made by using the absolute values (Gaensler, Patton, Verstraeten, and Badger, 1953; Gaensler and Wright, 1966) , while the values of MV, V02, DL, Dm,9 and VO were adjusted according to the body surface area (Bader, Bader, Rose, and Braunwald, 1955; Forster et al., 1957; McNeill, Rankin, and Forster, 1958; Gazioglu and Yu, 1967) . VO was corrected for a normal blood haemoglobin of 14-9 g./100 ml. by measuring the subject's haemoglobin at each study. All studies were carried out in the sitting position except for MEFV and FVC measurements which were performed in the standing position.
RESULTS
The physical characteristics of the normal subjects and of the patients with cardiopulmonary disease are presented in Table I . In all patients, the severity of the disease before and following pregnancy was relatively mild without interfering with their usual household activities. In one patient Normal subjects..
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.. 3-7 3-8 3-6 3-7 2-7 2-7 2-6 2-6 1-0 1.1 1-0 1-1 0-8 1-0 09 0-8 Emphysema .. In patients with emphysema, total lung capacity (TLC) increased from 4-4 litres (post-partum) to 51 litres at 36 weeks, and the RV/TLC increased slightly as a result of more increase in RV (0-5 litre) than that in VC (0-2 litre). In patients with predominant aortic valve disease and in those with sarcoidosis, no appreciable change of lung volumes was observed.
Percentage changes of MV, V02, and VEO9 in pregnant women are depicted in Fig. 1 . In normal subjects, maximum changes of MV and VEO2
were observed in the 24th week of pregnancy. Increased MV was due to an increased tidal volume (TV), since respiratory rate (RR) remained unchanged. There was an overall 8 % increase in VO, toward the term. These changes were not significant when they were expressed per body surface area (BSA).
In patients with valvular heart disease, MV and V02 increased more significantly than that observed in normal pregnant women. As a result of more increase in MV than in V02, an elevation of VEO2 was also observed. In patients with emphysema and in those with sarcoidosis, the changes of MV and V02, however, were insignificant.
The results of analysis of MEFV and FVC curves in pregnant women are illustrated in Fig. 2 Gaensler and his co-workers (1953, 1966) found no appreciable changes in maximal breathing capacity during late pregnancy in normal women. The studies of Rubin, Russo, and Goucher (1956) and Gee, Packer, Millen, and Robin (1967) indicated a decrease of total pulmonary resistance during pregnancy in normal women. Gee and his associates (1967) observed that a decrease in airway resistance was the major factor for reduction of total pulmonary resistance during pregnancy. In contrast, Krumholz, Echt, and Ross (1964) observed some increase in airway resistance in the last trimester of normal pregnancy, although the change was found to be statistically not significant. Likewise, analysis of MEFV and FVC curves obtained in the present study suggests no significant changes of airway resistance during pregnancy of normal women. Krumholz et al. (1964) reported no difference in DL, DM, and V0 in the first (14 weeks) and late (27 weeks) periods of pregnancy in normal women. In our studies DL and DM tended to decrease toward the last trimester of pregnancy, whereas V0 remained unchanged throughout. We found no correlation between a decrease in either DL or D. and the changes in lung volumes and ventilation. A lowered haemoglobin level may contribute to the corresponding decrease in total diffusing capacity as previously reported by Rankin, McNeill, and Forster (1961) . However, there was no correlation between DL and the haemoglobin level, which showed a slight decrease toward the term in some subjects.
Brown studied the oestrogen excretion of pregnant women (1959) and found that ovarian hormones increase during gestation and fall off abruptly after delivery. Pecora, Putnam, and Baum (1963) observed that intravenous oestrogens given to both male and female human subjects produced a statistically significant decrease in the DL as measured by the single breath method. They postulated that an injection of oestrogen caused an increase in acid mucopolysaccharides in the alveolar capillary zone which would tend to decrease DL. Rankin, McNeill, and Forster (1960) reported a correlation between the decrease in DL and the reduction of alveolar CO2 tension in non-pregnant subjects. In pregnancy, a lowered alveolar and arterial CO2 tension and a reduced blood plasma CO2 content and combining power have been repeatedly demonstrated by Hellegers, Metcalfe, Huckabee, Meschia, Prystowky, and Barron (1959) and Prowse and Gaensler (1965) . These changes are similar to those observed after acclimatization to high altitude and to those seen in patients with 'alveolar capillary block' syndrome. The importance of the ventilation-perfusion relationships in the gas exchange mechanism of the lung have been delineated by Cadigan, Marks, Ellicott, Jones, and Gaensler (1961) , Apthorp and Marshall (1961) , and Hatzfeld, Wiener, and Briscoe (1967) . It is possible that demands of the foetus and hormonal and mechanical effects of pregnancy may change the ventilation-perfusion ratio of the lung. Holley, Milic-Emili, Becklake, and Bates (1967) , employing a radioactive xenon technique, found that limitation of diaphragmatic excursion in obese subjects results in regional ventilation-perfusion abnormalities in the lower lung fields. This situation is somewhat similar to that found in pregnant women in terms of increased intra-abdominal distension and elevation of the diaphragm. Palmer, Gee, Mills, and Bates (1963) and Yu (1969) suggested that changes in cardiodynamics alone or combined with the aforementioned factors could reduce DL. In some nonpregnant patients with a mitral valve lesion an increase in V. as a result of pulmonary vascular congestion was reported by Palmer et al. (1963) and by Gazioglu and Yu (1967) and Yu (1969) .
In normal pregnant women V. is maintained at a fairly constant level despite increased blood volume. In contrast, a further increase in Vc was observed in pregnant women with mitral valve disease. Hypervolaemia in these patients not only augments the pulmonary blood capillary volume but also produces a disproportionate rise in the pulmonary vascular pressure. These changes may explain in part why some patients with mitral stenosis may develop acute pulmonary oedema during the later stage of pregnancy. Pregnant women with aortic valve disease showed no changes in parameters of pulmonary function tests except for their MV and V02, which were more appreciably increased than those observed in normal subjects.
In patients with emphysema, there was a progressive decrease in MEFV and FVC and a progressive increase in DL and Vc. Rankin et al. (1960) , Cadigan et al. (1961) , Apthorp and Marshall (1961) , and Hatzfeld et al. (1967) pointed out that uneven distribution of inspired gas in proportion to blood flow may often lead to an over-estimation of DL by the single-breath method in patients with obstructed airways. An increasing obstructive process during pregnancy in these patients and further disturbances in ventilation-perfusion relations may thus result in an over-estimation of DL and Vc. On the other hand, Forster and his colleagues (1957), Krumholz et al. (1964) , and Yu (1969) indicated that, in a given individual patient, the values are quite reproducible and that the results of serial measurements should provide useful information conceming the status of the pulmonary capillary bed. Therefore, it is possible that true DL and V, do increase in these subjects. We are not certain as to the exact mechanism of these changes as far as this study is concerned. Helpful information may be obtained by haemodynamic examination during pregnancy in emphysematous women.
Unaltered parameters of pulmonary function during pregnancy in patients with sarcoidosis suggest that these patients can tolerate pregnancy better than those with either cardiac disease or emphysema.
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